World Health Organization. (2024). External Contributor (A.K. Boggild). International travel and health collection: module 5: mental, neurological and substance use conditions. World Health Organization. https://iris.who.int/handle/10665/377618. License: CC BY-NC-SA 3.0 IGO.
World Health Organization. (2024). External Contributor (A.K. Boggild). International travel and health collection: module 2: environmental health risks. World Health Organization. https://iris.who.int/handle/10665/378100. License: CC BY-NC-SA 3.0 IGO.
World Health Organization. (2024). External Contributor (A.K. Boggild). International travel and health collection: module 1: general health risks and considerations for travellers. World Health Organization. https://iris.who.int/handle/10665/377996. License: CC BY-NC-SA 3.0 IGO
World Health Organization. External Experts Group (A.K. Boggild, Chair). Syndromic entry and exit screening for epidemic-prone diseases of travellers at ground crossings: evidence review and a call for research. Geneva, Switzerland. 2024.
World Health Organization. International Travel and Health Guideline Development Group (A.K. Boggild, Chair). Syndromic screening for COVID-19 of travellers crossing land borders. Geneva, Switzerland. 21 Dec 2022.
Libman M (Chair), Lagacé-Wiens P, Boggild AK, Vaughan S, Lee J, Bui Y, Schofield S, Rossi C, Tunis M, Jensen C Farmanara N, for the Committee to Advise on Tropical Medicine and Travel (CATMAT).
Statement on COVID-19 and International Travel: An Advisory Committee Statement (ACS). Government of Canada; 17 Dec 2021
Technical considerations for implementing a risk-based approach to international travel in the context of COVID-19: interim guidance : annex to: Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19. Geneva, Switzerland. 2 July 2021.
International Travel and Health Guideline Development Group (A.K. Boggild, Chair). Evidence review – Public health measures in the aviation sector in the context of COVID-19: quarantine and isolation. Geneva, Switzerland. 21 May 2021. Weekly Epidemiological Record 2021;96:165–172.
International Travel and Health Guideline Development Group (A.K. Boggild, Chair). Annexes to Weekly Epidemiological Record (WER) evidence review: public health measures in the aviation sector in the context of COVID-19: quarantine and isolation: tables and figures for ethical and equity considerations. Geneva, Switzerland. 21 May 2021.
International Travel and Health Guideline Development Group (A.K. Boggild, Chair). Evidence to recommendations: Methods used for assessing health equity and human rights considerations in COVID-19 and aviation. Geneva, Switzerland. 23 December 2020.
International Travel and Health Guideline Development Group (A.K. Boggild, Chair). Evidence to recommendation: COVID-19 mitigation in the aviation sector. Geneva, Switzerland. 27 November 2020.
McDonald P, Boggild AK, McCarthy A, for the Committee to Advise on Tropical Medicine and Travel (CATMAT).
Chapter 8 – Drugs for the prevention and treatment of malaria: Canadian recommendations for the prevention and treatment of malaria. Government of Canada; Updated DEC 2019.
Libman M, Boggild AK, Bui Y, Brophy J, Drebot M, Geduld J, Safronetz D, Schofield S, Tataryn J, Vanschalkwyk J, Yudin M.
Canadian Recommendations on the Prevention and Treatment of Zika Virus. Prepared by the Committee to Advise on Tropical Medicine and Travel. (Canada): Government of Canada; Updated 24-Dec-2019.
Zika Working Group: Libman M, Boggild AK, Bui Y, Brophy J, Drebot M, Geduld J, Safronetz D, Schofield S, Tataryn J, Vanschalkwyk J, Yudin M, for the Committee to Advise on Tropical Medicine and Travel (CATMAT).
Canadian Recommendations on the Prevention and Treatment of Zika Virus: Update. Canada Communicable Disease Report 2016;42:101-111.
Libman M, Boggild AK, Bui Y, Brophy J, Drebot M, Geduld J, Safronetz D, Schofield S, Tataryn J, Vanschalkwyk J, Yudin M.
Canadian Recommendations on the Prevention and Treatment of Zika Virus. Prepared by the Committee to Advise on Tropical Medicine and Travel. (Canada): Government of Canada; 2016 Feb.
Boggild AK, Brophy J, Charlebois P, Crockett M, Geduld J, Ghesquiere W, McDonald P, Plourde P, Teitelbaum P, Tepper M, Schofield S, McCarthy A.
Summary of recommendations on malaria issues in special hosts by the Committee to Advise on Tropical Medicine and Travel (CATMAT). Public Health Agency of Canada; 2014. Canada Communicable Disease Reports 2014; 40(10):178-190.
Boggild AK, Brophy J, Charlebois P, Crockett M, Geduld J, Ghesquiere W, McDonald P, Plourde P, Teitelbaum P, Tepper M, Schofield S, McCarthy A.
Summary of recommendations for the prevention of malaria by the Committee to Advise on Tropical Medicine and Travel (CATMAT). Public Health Agency of Canada; 2014. Canada Communicable Disease Reports 2014; 40(7);118-130.
Boggild AK, Brophy J, Charlebois P, Crockett M, Geduld J, Ghesquiere W, McDonald P, Plourde P, Teitelbaum P, Tepper M, Schofield S, McCarthy A.
Summary of recommendations for the diagnosis and treatment of malaria by the Committee to Advise on Tropical Medicine and Travel (CATMAT). Public Health Agency of Canada; 2014. Canada Communicable Disease Reports 2014; 40(7);131-141.
Boggild AK, Brophy J, Charlebois P, Crockett M, Geduld J, Ghesquiere W, McDonald P, Plourde P, Teitelbaum P, Tepper M, Schofield S, McCarthy A.
Canadian Recommendations for the Prevention and Treatment of Malaria: An Advisory Committee Statement. Committee to Advise on Tropical Medicine and Travel (CATMAT). Public Health Agency of Canada; 2014.
Joined the lab from Sep 2015 – present as a PhD candidate at the University of Toronto, and is currently completing a Clinical Microbiology Fellowship at the University of Alberta.
Joined the lab from June 2014 – present as a BSc Candidate at McMaster University, and is currently completing his MSc in Medical Sciences at the University of Toronto in the Boggild Lab.